BMC Nephrology

Table 3 MCP-1 associations in the unadjusted and fully adjusted models

From: Relationships between serum MCP-1 and subclinical kidney disease: African American-Diabetes Heart Study

Outcome	Unadjusted			Adjusted
Outcome	Estimate	StdErr	P-value	Estimate	StdErr	P-value
Log(Diabetes duration)	0.00060	0.00033	0.07	0.0003	0.0003	0.34
1/(HbA1c)	2.71E-06	1.248E-05	0.83	−7.70E-06	1.23E-05	0.53
1/sqrt(BMI)	−1.37E-05	8.53E-06	0.11	−2.02E-05	8.28E-06	0.01
Log(hsCRP)	0.0003	0.0006	0.54	−0.0001	0.0007	0.87
Log(CAC+1)	0.0006	0.001	0.57	−0.0003	0.0015	0.82
Log(CarCP+1)	0.0001	0.0008	0.86	−0.0012	0.0011	0.31
Log(AorCP+1)	0.0013	0.0012	0.25	−0.001	0.0015	0.48
Log(Urine ACR+1)	0.0013	0.0007	0.09	0.0021	0.001	0.04
Log(MDRD eGFR)	−0.0005	0.0001	<.0001	−0.0005	0.0001	0.006
Log(CKD-EPI eGFR)	−0.0004	0.0001	<.0001	−0.0003	0.0001	0.001

MCP-1, monocyte chemoattractant protein-1; HbA1c, hemoglobin A1c; BMI, body mass index; hsCRP, high sensitivity C-reactive protein; CAC, coronary artery calcified plaque; CarCP, carotid artery calcified plaque; AorCP, infrarenal aorta calcified plaque; ACR, albumin: creatinine ratio; eGFR, estimated glomerular filtration rate.
Adjusted model includes age, sex, smoking, HbA1c, BMI, and LDL-cholesterol.

Back to article page

ISSN: 1471-2369

Contact us

Submission enquiries: bmcnephrology@biomedcentral.com
General enquiries: ORSupport@springernature.com